Revenue
attach_money9M USD
-
PLXProtalix BioTherapeutics, Inc.$ --
Protalix BioTherapeutics, Inc.
PLX
$ -
-
Review earnings summary, surprise history, and upcoming forecasts.
analyticsEarnings Summary
FY2025 Q4Updated: 12/31/2025
Operating Income
trending_up-5M USD
-
Net Income
verified-6M USD
-
EPS
paid-0.07$
-
Revenue
$9.1M
MISS
$21.6M
$10.1M
$15.5M
$15.7M
$17.9M
$17.9M
$18.3M
$9.1M
$73.3M
$52.7M
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-
Net Income
$-5.5M
MISS
$6.3M
$-3.6M
$3.1M
$164,000
Q2
$4.3M
$2.4M
Q3
$3.1M
$-5.5M
$16.9M
$-6.6M
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-
Surprise History
ActualEstimate
FY2025MISS